Skip to main content
OpenTrials
Completed

NCT Number: NCT05967858

Incidence of Refeeding Syndrome in Consecutively Admitted Patients

The incidence and main risk-factors analyzed in consecutive in-patients in the departments og gastroenterology and ear-nose and throat diseases (cancer in radiation therapy)

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

Patients with either parenteral- or tube feeding enter the study to assure sufficient nutrition.

During hospitalization patients were monitored with daily blood samples and clinical evaluation of symptoms in addition to the coverage of energy and protein in percent of estimated needs.

Refeeding phenomenon was defined as a decrease in plasma phosphate after the initiation of nutrition.

Refeeding syndrome as refeeding phenomenon and one or more relevant symptoms in addition (hypotension, cardiac arrhythmia, edema, confusion)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • planned tube- or parenteral nutrition (complete or supplementary)
  • > 18 years
  • written consent

Exclusion criteria

  • Renal insufficiency (p-creatinine >200 micromol/l)
  • Lack of ability to communicate (registration of nutritional intake etc)

Treatment and study plan

observation

Other

no intervention

Primary outcomes

  1. Refeeding syndrome

    Time frame: 1 week after start of nutrition

    No. patients with decrease in plasma phosphate + clinical symptoms

Secondary outcomes

  1. Refeeding phenomenon

    Time frame: 1 week after start of nutrition

    No. patients with decrease in plasma phosphate after start of nutrition

Sponsors and collaborators

Lead sponsor

Jens Rikardt Andersen

Other

Collaborators

  • St. Olavs Hospital

Registry information

Official study title

Refeeding Syndrome - Incidence and Risk Factors: An Observational Study on Patients With G-I Disease and Head-neck Cancer

Important dates

Study start
2013
Primary completion
2014
Study completion
2023
First posted
Aug 1, 2023
Registry last updated
Aug 14, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.